LeMaitre Vascular Raises FY2024 GAAP EPS Guidance from $1.82-1.91 to $1.91-1.96 vs $1.85 Est; Raises FY2024 Sales Guidance from $216.80M-220.80M to $219.00M-221.00M vs $218.32M Est
Portfolio Pulse from Benzinga Newsdesk
LeMaitre Vascular has increased its FY2024 GAAP EPS guidance to $1.91-1.96, surpassing the analyst estimate of $1.85. The company also raised its FY2024 sales outlook to $219.00M-221.00M, exceeding the $218.32M estimate.
October 31, 2024 | 8:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LeMaitre Vascular has raised its FY2024 GAAP EPS guidance to $1.91-1.96, above the analyst estimate of $1.85. The sales outlook has also been increased to $219.00M-221.00M, exceeding the $218.32M estimate.
The increase in both EPS and sales guidance above analyst estimates suggests a positive outlook for LeMaitre Vascular, likely leading to a short-term stock price increase. The guidance revision indicates strong expected performance, which is typically viewed favorably by investors.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100